Literature DB >> 20237557

Cancer: a lower bar for senescence.

Manuel Serrano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20237557     DOI： 10.1038/464363a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  Large genome rearrangements as a primary cause of aging.

Authors:  Jan Vijg; Martijn E T Dollé
Journal:  Mech Ageing Dev       Date:  2002-04-30       Impact factor: 5.432

2.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

3.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

Review 4.  Cellular senescence in cancer and aging.

Authors:  Manuel Collado; Maria A Blasco; Manuel Serrano
Journal:  Cell       Date:  2007-07-27       Impact factor: 41.582

Review 5.  Regulation of the cell cycle by SCF-type ubiquitin ligases.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Semin Cell Dev Biol       Date:  2005-06       Impact factor: 7.727

Review 6.  Senescence in tumours: evidence from mice and humans.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Authors:  Stefano Campaner; Mirko Doni; Per Hydbring; Alessandro Verrecchia; Lucia Bianchi; Domenico Sardella; Thomas Schleker; Daniele Perna; Susanna Tronnersjö; Matilde Murga; Oscar Fernandez-Capetillo; Mariano Barbacid; Lars-Gunnar Larsson; Bruno Amati
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

9.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962
  9 in total
  9 in total

1.  Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway.

Authors:  Huanhuan Jin; Naqi Lian; Mianli Bian; Chenxi Zhang; Xingran Chen; Jiangjuan Shao; Li Wu; Anping Chen; Qinglong Guo; Feng Zhang; Shizhong Zheng
Journal:  Cell Prolif       Date:  2018-01-10       Impact factor: 6.831

2.  Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma.

Authors:  Jing Peng; Asmitananda Thakur; Shuo Zhang; Yuanfeng Dong; Xiaoqin Wang; Ruili Yuan; Kaige Zhang; Xuan Guo
Journal:  Tumour Biol       Date:  2015-06-02

3.  Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.

Authors:  Alejandro Vazquez-Martin; Eugeni López-Bonetc; Sílvia Cufí; Cristina Oliveras-Ferraros; Sonia Del Barco; Begoña Martin-Castillo; Javier A Menendez
Journal:  Drug Resist Updat       Date:  2011-05-19       Impact factor: 18.500

Review 4.  Active surveillance for low-risk prostate cancer.

Authors:  Laurence Klotz
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

5.  A comparison of 100 human genes using an alu element-based instability model.

Authors:  George W Cook; Miriam K Konkel; Jerilyn A Walker; Matthew G Bourgeois; Mitchell L Fullerton; John T Fussell; Heath D Herbold; Mark A Batzer
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

6.  Gerosuppressant metformin: less is more.

Authors:  Javier A Menendez; Sílvia Cufí; Cristina Oliveras-Ferraros; Luciano Vellon; Jorge Joven; Alejandro Vazquez-Martin
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

Review 7.  Metformin: multi-faceted protection against cancer.

Authors:  Sonia Del Barco; Alejandro Vazquez-Martin; Sílvia Cufí; Cristina Oliveras-Ferraros; Joaquim Bosch-Barrera; Jorge Joven; Begoña Martin-Castillo; Javier A Menendez
Journal:  Oncotarget       Date:  2011-12

8.  Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.

Authors:  Mayuko Nishi; Hidenori Akutsu; Ayumi Kudoh; Hirokazu Kimura; Naoki Yamamoto; Akihiro Umezawa; Sam W Lee; Akihide Ryo
Journal:  Oncotarget       Date:  2014-09-30

9.  Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence.

Authors:  H Jin; N Lian; F Zhang; L Chen; Q Chen; C Lu; M Bian; J Shao; L Wu; S Zheng
Journal:  Cell Death Dis       Date:  2016-04-14       Impact factor: 8.469
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.